Global Mitotane Market Size by Indication (Adrenal Cortical Carcinoma, Cushing's Syndrome), by End User (Hospital Pharmacies, Retail Pharmacies) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261439
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Mitotane drug is commonly used as a steroidogenesis inhibitor and cytostatic antineoplastic medication which is used for the treatment of adrenocortical carcinoma and Cushing\'s syndrome. It is also used as a chemotherapy drug which is used to treat a rare cancer of the adrenal glands called adrenal cortical carcinoma.

The global mitotane market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The mitotane Market is mainly driven by the increasing prevalence of adrenocortical carcinoma and pituitary adenomas. However, adverse side effects of treatment is one of the major factors expected to hamper the growth of the global market.

The global mitotane market is primarily segmented based on different Indication, end user and regions. On the basis of Indication, the market is divided into adrenal cortical carcinoma, cushing’s syndrome and others. Depending on end user, it is categorized into hospital pharmacies, retail pharmacies, online pharmacies and specialty clinics. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of Indication, the market is split into:
* Adrenal Cortical Carcinoma
* Cushing’s Syndrome
* Others

On the basis of end user, the market is split into:
* Hospital Pharmacies
* Retail Pharmacies
* Online Pharmacies
* Specialty Clinics

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Cipla Inc.
* Sun Pharmaceutical Industries Ltd.
* Johnson and Johnson AG
* Merck & Co., Inc.
* Vita-Cos-Med Klett-Loch GmbH
* HRA Pharma
* Bristol-Myers Squibb Company
These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, Indication and end user market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, Indication and end user with qualitative and quantitative information and facts

Target Audience:
* Mitotane Drug Manufacturers Providers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Mitotane Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Mitotane Market - Porter\'s Five Forces Analysis
4.4. Global Mitotane Market - PESTEL Analysis

5. Global Mitotane Market, by Indication
5.1. Global Mitotane Market, Size and Forecast, 2015-2026
5.2. Global Mitotane Market, by Adrenal Cortical Carcinoma, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Mitotane Market, by Cushing\'s Syndrome, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Mitotane Market, by Others, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026

6. Global Mitotane Market, by End User
6.1. Global Mitotane Market, Size and Forecast, 2015-2026
6.2. Global Mitotane Market, by Hospital Pharmacies, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Mitotane Market, by Retail Pharmacies, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Mitotane Market, by Online Pharmacies, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Mitotane Market, by Specialty Clinics, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Mitotane Market, by Region
7.1. Mitotane Market Regional Analysis, 2015-2026
7.2. Global Mitotane Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Mitotane Market, 2015-2026
7.3.1. North America Mitotane Market Size and Forecast, 2015-2026
7.3.2. North America Mitotane Market by Country, 2015-2026
7.3.2.1. U.S. Mitotane Market, 2015-2026
7.3.2.2. Canada Mitotane Market, 2015-2026
7.4. Europe Mitotane Market, 2015-2026
7.4.1. Europe Mitotane Market Size and Forecast, 2015-2026
7.4.2. Europe Mitotane Market by Country, 2015-2026
7.4.2.1. Germany Mitotane Market, 2015-2026
7.4.2.2. France Mitotane Market, 2015-2026
7.4.2.3. Italy Mitotane Market, 2015-2026
7.4.2.4. UK Mitotane Market, 2015-2026
7.4.2.5. Spain Mitotane Market, 2015-2026
7.4.2.6. Rest of Europe Mitotane Market, 2015-2026
7.5. Asia Pacific Mitotane Market, 2015-2026
7.5.1. Asia Pacific Mitotane Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Mitotane Market by Country, 2015-2026
7.5.2.1. Japan Mitotane Market, 2015-2026
7.5.2.2. China Mitotane Market, 2015-2026
7.5.2.3. India Mitotane Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Mitotane Market, 2015-2026
7.6. South America Mitotane Market, 2015-2026
7.6.1. South America Mitotane Market Size and Forecast, 2015-2026
7.6.2. South America Mitotane Market by Country, 2015-2026
7.6.2.1. Mexico Mitotane Market, 2015-2026
7.6.2.2. Brazil Mitotane Market, 2015-2026
7.6.2.3. Rest of South America Mitotane Market, 2015-2026
7.7. Middle East & Africa Mitotane Market, 2015-2026
7.7.1. Middle East & Africa Mitotane Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Mitotane Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Mitotane Market, 2015-2026
7.7.2.2. South Africa Mitotane Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Mitotane Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Cipla Inc.
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Sun Pharmaceutical Industries Ltd.
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Johnson and Johnson AG
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Merck & Co., Inc.
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Vita-Cos-Med Klett-Loch GmbH
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. HRA Pharma
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Bristol-Myers Squibb Company
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
10. Key Insights

Content are not available

Choose License Type